Author:
Wang Yun-Chang,Li Rong-Rong,Cai Yi,Wei Zi-Yi,Shao Chang-Liang
Abstract
Abstract
Aim
To study the short-term change of macular function and the correlates after intravitreal conbercept for CRVO-ME.
Study design
Prospective, clinical study.
Methods
Twenty Three patients(23 eyes) were recruited, who were non-ischemia central retinal vein occlusion diagnosed by FFA (fundus fluorescein angiography) and treated with intravitreal conbercept for macular edema, best – corrected visual acuity ( BCVA), central macular thickness(CMT), amplitude density of P1 wave and implicit time of P1,N1 wave from ring 1 and ring 2 of mf-ERG were measured before and 1 week、2 month after treatment.
Results
Compared to the baseline, BCVA、CMT、amplitude density of P1 wave and implicit time of P1,N1 wave from ring 1 and ring 2 were greatly improved at 1 W、2 M after treatment; better results were gained at 2 M compared to 1 W; Pearson correlation analysis shows no significantly correlation between the improvement of mf-ERG with the change of BCVA、CMT.
Conclusion
The BCVA、the structure and the function of macular were greatly improved after intravitreal conbercept for central retinal vein occlusion induced macular edema; however no significantly correlation between the improvement of the function of macular with the strcture of macular and BCVA.
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference17 articles.
1. Sun Z, Zhou H, Lin B, et al. EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION. Retina. 2017;37(9):1723–30.
2. Torres-Soriano ME, Cubas-Lorenzo V, García-Aguirre G, et al. Multifocal electrophysiologic findings after intravitreal bevacizumab (avastin) treatment. Retina. 2012;32(5):972–6.
3. Hood DC, Bach M, et al. "ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition)." Doc Ophthalmol. 2012;124:1–13.
4. Yan ZP, Wang CH. Short-term efficacy of appercept in the treatment of macular edema secondary to retinal vein occlusion. Int J Ophthalmol. 2020;20(7):1253–6.
5. Yang J, Zhang YL, Yang N, et al. Clinical efficacy and prognostic factors of ranibizumab in BRVO-ME. Int J Ophthalmol. 2020;20(4):673–9.